DOI QR코드

DOI QR Code

Epidemiological characteristics of hospital-onset bloodstream infections and risk factors for peripheral venous catheter-associated bloodstream infections at a general hospital in South Korea: a retrospective case-control study

한국 일개 종합병원의 병원발생 혈류감염의 역학적 특성 및 말초정맥카테터 관련 혈류감염의 위험요인 분석: 후향적 사례-대조군 연구

  • Received : 2025.01.04
  • Accepted : 2025.02.05
  • Published : 2025.02.28

Abstract

Purpose: This study investigated the incidence of hospital-onset bloodstream infections (HOBSI) and risk factors for HOBSI among patients with peripheral venous catheters (PVCs) at a general hospital. Methods: A retrospective case-control study was conducted on patients hospitalized between August 1, 2021, and July 31, 2023. The case group included 31 patients diagnosed with bloodstream infections, while the control group included 93 patients without bloodstream infections. The control group were matched to the case group at a 1:3 ratio using propensity score matching. Data were analyzed using the chi-square test, t-test, and logistic regression analysis. Results: The incidence density per 1,000 patient-days was 0.61 for HOBSI-1, 0.40 for HOBSI-2, and 0.25 for central line-associated bloodstream infections (CLABSI). Approximately 70%-80% of bloodstream infections were found to occur in general wards. Multivariate analysis revealed that prolonged hospital stays (odds ratio [OR] =1.03) and liver cirrhosis (OR = 14.76) were significant risk factors for PVC-associated bloodstream infection (PVC-BSI). The mortality rate in the case group was significantly higher, with a 22.08-fold increased risk compared to the control group. Conclusion: This study revealed that HOBSI had a higher incidence rate than CLABSI, with the majority of cases occurring in general wards. HOBSI surveillance demonstrated relatively higher sensitivity, which can be beneficial for identifying bloodstream infections in hospitals with low catheter usage. Given the high mortality risk, PVC-BSI require increased attention. This study provides valuable data for improving bloodstream infection prevention strategies.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF2020R1G1A1102533).

References

  1. Korean National Healthcare-associated Infections Surveillance System. KONIS ICU manual 2022 [Internet]. Seoul: Korean Society for Healthcare-associated Infection Control; 2022 [cited 2023 Dec 14]. Available from: http://konis.cafe24.com/xe/index.php?mid=manual&category=251&document_srl=25300
  2. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. The New England Journal of Medicine. 2006;355(26):2725–2732. https://doi.org/10.1056/NEJMoa061115
  3. Maki DG, Crnich CJ. Line sepsis in the ICU: prevention, diagnosis, and management. Seminars in Respiratory and Critical Care Medicine. 2003;24(1):23–36. https://doi.org/10.1055/s-2003-37914
  4. Kim EJ, Kwak YG, Kwak SH, Ko SH, Kweon OM, Kim ES, et al. Korean national healthcare-associated infections surveillance system, intensive care unit module report: summary of data from july 2020 through june 2021. Korean Journal of Healthcare-associated Infection Control and Prevention. 2023;28(1):64–77. https://doi.org/10.14192/kjicp.2023.28.1.64
  5. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proceedings. 2006;81(9):1159–1171. https://doi.org/10.4065/81.9.1159
  6. Burke JP. Infection control - a problem for patient safety. The New England Journal of Medicine. 2003;348(7):651–656. https://doi.org/10.1056/NEJMhpr020557
  7. Korean National Healthcare-associated Infections Surveillance System. KONIS HH/CLABSI manual 2023 [Internet]. Seoul: Korean Society for Healthcare-associated Infection Control; 2023 [cited 2023 Dec 14]. Available from: http://konis.cafe24.com/xe/index.php?mid=pds_hh&category=3073&document_srl=28010
  8. Park ES, Jin HY, Jeong SY, Kweon OM, Yoo SY, Park SY, et al. Healthcare-associated infection surveillance in small and medium sized hospitals. Korean Journal of Nosocomial Infection Control. 2011;16(2):54–62.
  9. Gurney H, White J, Sweeney J, Valyko A, Washer L. Evaluation of hospital-onset bloodstream infections compared to central line-associated bloodstream infections at an acute, tertiary care hospital. American Journal of Infection Control. 2023;51(10):1120–1123. https://doi.org/10.1016/j.ajic.2023.04.001
  10. Sturm L, Service N, Bufalino A, Huang R, Sharma M, Erlinger T, et al. Is hospital-onset bloodstream infection (HOBSI) a useful measure to evaluate infection prevention progress? Infection Control & Hospital Epidemiology. 2020;41(S1):s307–s308. https://doi.org/10.1017/ice.2020.894
  11. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases. 2004;39(3):309–317. https://doi.org/10.1086/421946
  12. Mestre G, Berbel C, Tortajada P, Alarcia M, Coca R, Fernández MM, et al. Successful multifaceted intervention aimed to reduce short peripheral venous catheter-related adverse events: a quasiexperimental cohort study. American Journal of Infection Control. 2013;41(6):520–526. https://doi.org/10.1016/j.ajic.2012.07.014
  13. Pujol M, Hornero A, Saballs M, Argerich MJ, Verdaguer R, Cisnal M, et al. Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital. Journal of Hospital Infection. 2007;67(1):22–29. https://doi.org/10.1016/j.jhin.2007.06.017
  14. Ritchie S, Jowitt D, Roberts S. The Auckland city hospital device point prevalence survey 2005: utilisation and infectious complications of intravascular and urinary devices. The New Zealand Medical Journal. 2007;120(1260):U2683.
  15. Vandenbos F, Basar A, Tempesta S, Fournier JP, Bertrand F, Vanesland L, et al. Relevance and complications of intravenous infusion at the emergency unit at Nice university hospital. Journal of Infection. 2003;46(3):173–176. https://doi.org/10.1053/jinf.2002.1101
  16. Zingg W, Pittet D. Peripheral venous catheters: an under-evaluated problem. International Journal of Antimicrobial Agents. 2009;34(4):S38–S42. https://doi.org/10.1016/S0924-8579(09)70565-5
  17. Delgado-Capel M, Gabillo A, Elias L, Yébenes JC, Sauca G, Capdevila JA. Características de la bacteriemia relacionada con catéter venoso periférico en un hospital general. Revista Española de Quimioterapia. 2012;25(2):129–133.
  18. Mermel LA. Short-term peripheral venous catheter–related bloodstream infections: a systematic review. Clinical Infectious Diseases. 2017;65(10):1757–1762. https://doi.org/10.1093/cid/cix562
  19. Zanella M, Pianca E, Catho G, Obama B, De Kraker MEA, Nguyen A, et al. Increased peripheral venous catheter bloodstream infections during COVID-19 pandemic, Switzerland. Emerging Infectious Diseases. 2024;30(1):159–162. https://doi.org/10.3201/eid3001.230183
  20. Korean Society for Healthcare-associated Infection Control. Healthcare associated infection – control and prevention. 1st ed. Paju: Koonja Publishing Inc; 2023. p. 530–541.
  21. Zhang L, Cao S, Marsh N, Ray-Barruel G, Flynn J, Larsen E, et al. Infection risks associated with peripheral vascular catheters. Journal of Infection Prevention. 2016;17(5):207–213. https://doi.org/10.1177/1757177416655472
  22. Iwagami M, Shinozaki T. Introduction to matching in case-control and cohort studies. Annals of Clinical Epidemiology. 2022;4(2):33–40. https://doi.org/10.37737/ace.22005
  23. Lee DK. An introduction to propensity score matching methods. Anesthesia and Pain Medicine. 2016;11(2):130–148. https://doi.org/10.17085/apm.2016.11.2.130
  24. Centers for Disease Control and Prevention. National Healthcare Safety Network (NHSN) Patient Safety Component Manual [Internet]. Atlanta: Centers for Disease Control and Prevention; 2023 [cited 2023 Dec 14]. Available from: https://www.cdc.gov/nhsn/psc/index.html
  25. Kim JJ, Kang H, Khan AN, Wang R, Casale SC, Barker CMA, et al. A comparison of national healthcare safety network surveillance definitions to physician review for central-line–associated bloodstream infections. Infection Control & Hospital Epidemiology. 2023;44(12):2062–2064. https://doi.org/10.1017/ice.2023.128
  26. Krishnan J, Gettler EB, Campbell M, Kalu IC, Seidelman J, Smith B, et al. Comparative epidemiology of hospital-onset bloodstream infections (HOBSIs) and central line-associated bloodstream infections (CLABSIs) across a three-hospital health system. Infection Control & Hospital Epidemiology. 2024;45(8):952–958. https://doi.org/10.1017/ice.2024.38
  27. Mitchell BG, Hall L, Halton K, MacBeth D, Gardner A. Time spent by infection control professionals undertaking healthcare associated infection surveillance: a multi-centred cross sectional study. Infection, Disease & Health. 2016;21(1):36–40. https://doi.org/10.1016/j.idh.2016.03.003
  28. Brownstein JS, Rader B, Astley CM, Tian H. Advances in artificial intelligence for infectious-disease surveillance. The New England Journal of Medicine. 2023;388(17):1597–1607. https://doi.org/10.1056/NEJMra2119215
  29. dos Santos RP, Silva D, Menezes A, Lukasewicz S, Dalmora CH, Carvalho O, et al. Automated healthcare-associated infection surveillance using an artificial intelligence algorithm. Infection Prevention in Practice. 2021;3(3):100167. https://doi.org/10.1016/j.infpip.2021.100167
  30. Rosenthal VD, Belkebir S, Zand F, Afeef M, Tanzi VL, Al-Abdely HM, et al. Six-year multicenter study on short-term peripheral venous catheters-related bloodstream infection rates in 246 intensive units of 83 hospitals in 52 cities of 14 countries of Middle East: Bahrain, Egypt, Iran, Jordan, Kingdom of Saudi Arabia, Kuwait, Lebanon, Morocco, Pakistan, Palestine, Sudan, Tunisia, Turkey, and United Arab Emirates—International Nosocomial Infection Control Consortium (INICC) findings. Journal of Infection and Public Health. 2020;13(8):1134–1141. https://doi.org/10.1016/j.jiph.2020.03.012
  31. Seo HK, Hwang J, Shin MJ, Kim SY, Song K, Kim ES, et al. Two-year hospital-wide surveillance of central line-associated bloodstream infections in a Korean hospital. Journal of Korean Medical Science. 2018;33(45):e280. https://doi.org/10.3346/jkms.2018.33.e280
  32. Cho SY, Chung DR, Ryu JG, Choi JR, Ahn N, Kim S, et al. Impact of targeted interventions on trends in central line-associated bloodstream infection: a single-center experience from the Republic of Korea. Critical Care Medicine. 2017;45(6):e552–e558. https://doi.org/10.1097/CCM.0000000000002306
  33. Nutman A, Wullfhart L, Temkin E, Feldman SF, Schechner V, Schwaber MJ, et al. Hospital-onset bloodstream infections caused by eight sentinel bacteria: a nationwide study in Israel, 2018–2019. Microorganisms. 2022;10(5):1009. https://doi.org/10.3390/microorganisms10051009
  34. Shang J, Needleman J, Liu J, Larson E, Stone PW. Nurse staffing and healthcare-associated infection, unit-level analysis. The Journal of Nursing Administration. 2019;49(5):260–265. https://doi.org/10.1097/NNA.0000000000000748
  35. Mitchell BG, Gardner A, Stone PW, Hall L, Pogorzelska-Maziarz M. Hospital staffing and health care-associated infections: a systematic review of the literature. The Joint Commission Journal on Quality and Patient Safety. 2018;44(10):613–622. https://doi.org/10.1016/j.jcjq.2018.02.002
  36. Saliba P, Hornero A, Cuervo G, Grau I, Jimenez E, Berbel D, et al. Interventions to decrease short-term peripheral venous catheter-related bloodstream infections: impact on incidence and mortality. The Journal of Hospital Infection. 2018;100(3):e178–e186. https://doi.org/10.1016/j.jhin.2018.06.010
  37. Sato A, Nakamura I, Fujita H, Tsukimori A, Kobayashi T, Fukushima S, et al. Peripheral venous catheter-related bloodstream infection is associated with severe complications and potential death: a retrospective observational study. BMC Infectious Diseases. 2017;17(1):434. https://doi.org/10.1186/s12879-017-2536-0
  38. Tsuboi M, Hayakawa K, Mezaki K, Katanami Y, Yamamoto K, Kutsuna S, et al. Comparison of the epidemiology and microbiology of peripheral line– and central line–associated bloodstream infections. American Journal of Infection Control. 2019;47(2):208–210. https://doi.org/10.1016/j.ajic.2018.08.016
  39. Yoo S, Jung S, Kim G, Lim D, Sohn J, Kim J, et al. Interventions to prevent catheter-associated blood-stream infections: a multicenter study in Korea. Infection & Chemotherapy. 2010;42(4):216–222. https://doi.org/10.3947/ic.2010.42.4.216
  40. Thulstrup AM, Sørensen HT, Schønheyder HC, Møller JK, Tage-Jensen U. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clinical Infectious Diseases. 2000;31(6):1357–1361. https://doi.org/10.1086/317494
  41. Tonon M, Angeli P, Piano S. Bacterial infections in cirrhosis. Infectious Microbes & Diseases. 2021;3(3):117–124. https://doi.org/10.1097/IM9.0000000000000065
  42. Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World Journal of Gastroenterology. 2014;20(10):2542–2554. https://doi.org/10.3748/wjg.v20.i10.2542
  43. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426–1437. https://doi.org/10.1053/j.gastro.2013.02.042
  44. Roth JA, Widmer AF, Tschudin-Sutter S, Dangel M, Frei R, Battegay M, et al. The model for end-stage liver disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: a single-centre observational study. PloS One. 2017;12(4):e0175669. https://doi.org/10.1371/journal.pone.0175669